產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | E0771 (小鼠髓樣乳腺癌細(xì)胞) (STR鑒定正確) |
別稱 | Eo771; E0771; EO 771 |
種屬 | 小鼠 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40% FBS+5% DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:4-1:6 |
推薦換液頻率 | 2-3次/周 |
注意事項 | 1.細(xì)胞生長速度較快,請合理控制傳代比例;2.該細(xì)胞換液極易收縮,需預(yù)熱培養(yǎng)基;收貨如有細(xì)胞收縮為正?,F(xiàn)象,消化離心重新1:1傳代。 |
背景描述 | EO771 is an epithelial-like cell that was isolated from the mammary gland of a patient with carcinoma. The cells display an elongated morphology. Depositor note: cells are genetically unstable in continuous culture. The EO771 mammary tumor was first reported in 1948 as a spontaneous mammary carcinoma arising in a C57Bl/6 mouse. |
年齡(性別) | 雌性 |
組織來源 | 乳房;乳腺 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 乳腺癌細(xì)胞 |
生物安全等級 | BSL-1 |
倍增時間 | 24 hours |
應(yīng)用領(lǐng)域 | 該細(xì)胞系可用于分析調(diào)節(jié)乳腺癌轉(zhuǎn)移的基因和/或可能減少免疫活性C57Bl/6小鼠自發(fā)轉(zhuǎn)移的藥物。 |
保藏機構(gòu) | ATCC; CRL-3461 |
STR鑒定
-
STR位點信息
18-3 16,17,18 6-7 15,16 5-5 17,21 X-1 26,29 1-2 19,20,22 7-1 25.2,26.2 8-1 16 1-1 17,18,19 19-2 13 15-3 22.3,23.3,25.3 12-1 17,18 6-4 18,19,20 4-2 21.3,22.3,24.3 3-2 14,15 2-1 16,18 13-1 17.1,18.1
11-2 15.3,16.3 17-2 15,16 -
STR鑒定圖
-
參考文獻(xiàn)
-
Ginsenoside Rh1, a novel casein kinase II subunit alpha (CK2α) inhibitor, retards metastasis via disrupting HHEX/CCL20 signaling cascade involved in tumor cell extravasation across endothelial barrier (2023-11-07)
期刊:PHARMACOLOGICAL RESEARCH
DOI:10.1016/j.phrs.2023.106986
影響因子 :9.3
引用產(chǎn)品: E0771 細(xì)胞 , MDA-MB-231 細(xì)胞 , MS1 細(xì)胞
-
Cyclic diguanylate analogues: Facile synthesis, STING binding mode and anti-tumor immunity delivered by cytidinyl/cationic lipid (2022-12-26)
期刊:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1016/j.ejmech.2022.115053
影響因子 :7.1
引用產(chǎn)品: E0771 細(xì)胞 , RAW 264.7 細(xì)胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖